Table 4.
Clinicopathological features | Cases | P | CC+CT* (n) | P | CT+TT** (n) | P | ||
---|---|---|---|---|---|---|---|---|
| ||||||||
CC | CT | TT | ||||||
Tumor diameter | ||||||||
< 5 cm | 75 | 19 | 0 | 0.41 | 94 | 0.182 | 19 | 0.755 |
≥ 5 cm | 125 | 32 | 3 | 157 | 35 | |||
Infiltration depth | ||||||||
Unbroken-through serosal layer | 39 | 10 | 1 | 0.836 | 49 | 0.55 | 11 | 0.887 |
Broken-through serosal layer | 161 | 41 | 2 | 202 | 43 | |||
Lymphatic metastasis | ||||||||
No metastasis | 51 | 13 | 2 | 0.271 | 64 | 0.106 | 15 | 0.735 |
Metastasis existed | 149 | 38 | 1 | 187 | 39 | |||
TNM staging of tumor | ||||||||
0-І | 28 | 6 | 0 | 0.952 | 34 | 0.897 | 6 | 0.712 |
II | 45 | 9 | 1 | 54 | 10 | |||
III | 59 | 15 | 1 | 74 | 16 | |||
IV | 68 | 21 | 1 | 89 | 22 |
compared with TT;
compared with CC;
TNM, tumor node metastasis.